ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 15812 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 15812; 2) Community: the network communities that were significantly associated with the response to NSC 15812; 3) Molecule: the relationships between components within communities and NSC 15812; 4) MDR: the compounds that were significantly associated with the NSC 15812.

NSC Compound Enrichment Correlation
NSC 750762 2-methoxy-7-benzyl-3-(phenylsulfonyl)-6,7-dihydro-5H-pyrazolo[3,4-h]quinoline 0.0100995289754788 0.26037721
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0100995289754788 0.31284115
NSC 762009 Copper(II) complex with quin as a ligand 0.0100995289754788 0.44971829
NSC 763232 Null 0.0100995289754788 0.18967109
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.0100995289754788 0.24177032
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0100995289754788 0.27775116
NSC 87500 Solacongestidine 0.0100995289754788 0.39285965
NSC 112535 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-[m-[2-(p-nitro-phenoxy)ethoxy]phenyl]-, monohydrochloride (8CI) 0.0103070729572494 0.12263674
NSC 136036 Pentalenolactone 0.0103070729572494 -0.086811461
NSC 266743 Hydrazinecarbothioamide, 2-[(5-amino-2-pyridinyl)methylene]- 0.0103070729572494 0.1771812
Total:103  Current:30    [First] [Prev] [Next] [Last]